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Oxytocin is an important regulator of the social brain. In some animal models of autism, notably in Magel2tm1.1Mus-deficient mice,
peripheral administration of oxytocin in infancy improves social behaviors until adulthood. However, neither the mechanisms
responsible for social deficits nor the mechanisms by which such oxytocin administration has long-term effects are known. Here, we
aimed to clarify these oxytocin-dependent mechanisms, focusing on social memory performance. Using in situ hybridization (RNAscope),
we have established that Magel2 and oxytocin receptor are co-expressed in the dentate gyrus and CA2/CA3 hippocampal regions
involved in the circuitry underlying social memory. Then, we have shown that Magel2tm1.1Mus-deficient mice, evaluated in a three-
chamber test, present a deficit in social memory. Next, in hippocampus, we conducted neuroanatomical and functional studies using
immunostaining, oxytocin-binding experiments, ex vivo electrophysiological recordings, calcium imaging and biochemical studies. We
demonstrated: an increase of the GABAergic activity of CA3-pyramidal cells associated with an increase in the quantity of oxytocin
receptors and of somatostatin interneurons in both DG and CA2/CA3 regions. We also revealed a delay in the GABAergic development
sequence in Magel2tm1.1Mus-deficient pups, linked to phosphorylation modifications of KCC2. Above all, we demonstrated the positive
effects of subcutaneous administration of oxytocin in the mutant neonates, restoring hippocampal alterations and social memory at
adulthood. Although clinical trials are debated, this study highlights the mechanisms by which peripheral oxytocin administration in
neonates impacts the brain and demonstrates the therapeutic value of oxytocin to treat infants with autism spectrum disorders.
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INTRODUCTION
The nonapeptide oxytocin (OT) and its signaling pathway, the OT-
system, are important regulators in the development of the social
brain, suggesting that OT plays a role in both childhood and adult
neuropsychiatric disorders characterized by social cognition impair-
ment [1]. The OT-system is altered in several animal models of
neurodevelopmental disorders [2, 3]. Indeed, knockout (KO) mouse
models of oxytocin [4, 5], oxytocin receptor (Oxtr) [6–8], or ADP-ribosyl
cyclase (Cd38) [9, 10] genes show changes in social behavior
reminiscent of autism spectrum disorders (ASD). Additionally, several
rodent models of ASD due either to the inactivation of genes such as
Fmr1, Cntnap2, Magel2, Oprm1, Shank3, Nlgn-3, or environmental
valproic acid exposure (VPA), exhibit indirect impairment of the brain
OT-system [2]. MAGEL2 is a gene that is involved in Prader–Willi
(PWS) [11] and Schaaf-Yang (SYS) syndromes [12] and is classified as
one of the highest relevant gene to ASD risk (SFARI gene scoring),
indeed 75–80% of SYS patients meet the formal clinical diagnostic
criteria of ASD [13, 14]. Both of these genetic neurodevelopmental
disorders have in common autistic features with alterations in social
behavior and deficits in cognition that persist over the lifespan [15].
Magel2tm1.1Mus-deficient mouse model is a pertinent model for both
syndromes [15], mimicking alterations in social behavior and learning
abilities in adulthood [16, 17]. Magel2 is expressed in the developing
hypothalamus until adulthood and Magel2tm1.1Mus-KO neonates
display a deficiency of several hypothalamic neuropeptides,
particularly OT [18]. Daily administration of OT in Magel2-KO
neonates during the first week of life improves social behavior and
learning abilities beyond the treatment period lasting into adulthood
[16]. Comparable long-term effects have also been reported in
other genetic rodent models such as the VPA-induced rat model [19],
the Cntnap2, Fmr1 KO mice [20, 21], and following maternal
separation [22]. However, the neurobiological alterations involving
the OT-system and responsible for social behavior deficits in these
models are not known. Similarly, the mechanisms by which OT-
treatment in infancy exerts its long-lasting beneficial effects, remain
mysterious.
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At adulthood, OT is thought toregulate aspects of social
behavior via interactions with OXTRs in a number of key brain
regions [23]. Social recognition memory deficit in adulthood is a
robust phenotype, present in all the models with an alteration of
the OT-system [24]. With regard to social memory, a critical role
has been ascribed to hippocampal OXTR expression in the anterior
hilar dentate gyrus (aDG) and anterior CA2/CA3 distal regions
(aCA2/CA3d) [25–28]. In the aCA2/CA3d region, OXTRs are
expressed in glutamatergic pyramidal neurons and in GABAergic
interneurons, which account for over 90% of OXTR positive cells in
the hippocampus [29]. Notably, both types of neuron are
necessary for the formation of stronger synapses that mediate
long-term potentiation and social memory [25, 26, 30].
In the first two postnatal weeks, OT neuron projections develop
and the expression of OXTRs is extremely dynamic followed by a
decreased expression thereafter [31, 32]. However, during this
developmental period, the mechanisms by which the OT-system
shapes various behaviors are little studied. One study reports that
OT is involved in dendritic and synaptic refinement in immature
hippocampal glutamatergic neurons [33].
Five clinical trials (phase 1 or 2) of OT administration in patients
with PWS have been conducted, yielding positive or no effects, with
no adverse effects reported [34]. However, the intervention design
of each of the studies is rather exploratory, using different timings,
durations, and doses of OT, since we do not yet understand clearly
how OT works. Based on our previous preclinical studies [16, 18], a
phase 1/2 clinical trial with OT-treatment of infants with PWS
significantly improves early feeding and “social skills” [35], support-
ing the translational relevance of our study. More research is needed
to demonstrate and validate our hypothesis that the administration
of OT in early infancy might be the most beneficial treatment for
PWS/SYS. Thus, to build a strong scientific rationale for clinical
intervention, it is necessary to elucidate the PWS/SYS neuronal
alterations and the mechanisms underlying the long-lasting effects
of OT-administration in neonates.
Here, we aimed to clarify the physiological and cellular mechanisms
related to the OT-system that are disturbed inMagel2tm1.1Mus-deficient
mice and those responsible for the long-term rescue effects following
OT peripheral administration in pups. We focused our study on
the deficit of social memory, a robust phenotype linked to the OT-
system.
MATERIALS AND METHODS
Animals and primary hippocampal cultures
Magel2tm1.1Mus+/+ (WT) and Magel2tm1.1Mus−/− (Magel2-KO) mice were
maintained on a C57BL/6J genetic background. Experimental protocols
were approved by the institutional Ethical Committee guidelines for animal
research with the accreditation no. B13-055-19 from the French Ministry of
Agriculture. Magel2-deficient mice were generated as previously published
[18]. Embryonic day 18 dissociated hippocampal neurons were obtained
from timed pregnant mice. See Supplementary Information for details.
Oxytocin treatment
WT and Magel2-KO pups were removed from their mother, placed on a
heating pad, given a subcutaneous (s.c.) injection and quickly returned to
the mother. The solutions injected were isotonic saline (10 µl) for control
mice and 2 µg of OT (Phoenix Pharmaceuticals Inc., cat #051-01) diluted in
isotonic saline (10 µl) for treated mice.
Behavior
The effects of Magel2 deletion and OT-treatment were evaluated on social
behavior, locomotor and vertical activity, anxiety-like behavior and nonsocial
memory. For detailed procedures, see Supplementary Information.
Calcium imaging recordings
Calcium imaging experiments were carried out as previously reported [36]
and are described in Supplementary Information section.
Electrophysiological recordings and morphological analysis
Whole-cell patch clamp. Spontaneous and miniature synaptic activity was
recorded in voltage-clamp mode on P20–P25 CA3-pyramidal neurons.
The morphology of recorded aCA3d neurons was defined by adding
biocytin in the recording solution and performing Neurolucida reconstruc-
tion followed by a Sholl analysis. See Supplementary Information, for
details.
Single GABAA channel recordings were performed on hippocampal CA3-
pyramidal neurons at P1, P7, and P15 in cell-attached configuration, as
described in Supplementary Information.
Immunohistochemistry and quantification
Immunostaining was carried out on 50 μm-thick coronal sections following
standard procedure, as described in Supplementary Information.
OT-binding assay
Adult WT and mutant mice were killed and non-perfused mouse brain
were frozen in −25 °C isopentane and stored at −80 °C until cut. 14 µm-
thick brain slices were cut using a cryostat (Frigocut-2700, Reichert-Jung)
and collected on chromallume-coated slides and stored at −80 °C until
use. Localization of OT-binding sites was performed by autoradiography as
detailed in Supplementary Information.
Chromogenic in situ hybridization
Fresh-frozen brains from WT mice at P7 and P28 were sectioned in a
cryostat in the coronal plane at 20 μm thickness and mounted on
Superfrost Plus slides and stored at −80 °C. RNA detection was performed
on tissue sections using RNAscope 2.5HD Duplex Assay (Cat #322430,
Advanced Cell Diagnostics (ACD), Hayward, CA) as detailed in Supplemen-
tary Information.
Western blot
Western blotting experiments were performed on hippocampal tissue and
specific bands were visualized with secondary HRP-conjugated antibodies
using ChemiDoc™ Imaging Systems (Bio-Rad). The relative intensities of
immunoblot bands were determined by densitometry with ImageJ
software. See Supplementary Information for details.
Statistical analysis
Statistical analyses were performed using GraphPad Prism (GraphPad
Software, Prism 8.0 software, Inc, La Jolla, CA, USA). All the statistical
analyses are reported in a specific file. For details, see Supplementary
Information.
RESULTS
aDG and aCA2/CA3d regions co-express Magel2 and Oxtr
transcripts
Magel2 is known to be highly expressed in hypothalamus, while its
expression in hippocampal regions is less well characterized. Taking
into account the developmental and dynamic expression of Oxtr
[31, 32], we looked at the expression of Magel2 and Oxtr transcripts in
the anterior hippocampus at P7 and P28, using RNAscope technique.
At P7, we detected Oxtr and Magel2 mRNAs in the aCA2/CA3d region
with Magel2 more expressed in the deep layer of the stratum
pyramidale (Fig. 1A). At P28, the level ofMagel2 transcripts was reduced
but still present in the deep layer of aCA2/CA3d region and Oxtr
transcripts were also strongly expressed in pyramidal cells. Expression
of Magel2 and Oxtr was also detected in few cells of the stratum oriens
and stratum radiatum where co-expression can be observed. In the DG,
an expression of Oxtr and Magel2 was detected in the hilus, with co-
localization of both transcripts. Then, in parallel, we extracted data from
public RNAseq data libraries obtained in adult mice (Allen brain;
Linnarson lab: http://celltypes.brain-map.org/rnaseq/mouse/cortex-and-
hippocampus; http://mousebrain.org/genesearch.html). It appears that
Oxtr and Magel2 are co-expressed in CA3 excitatory neurons
(expressing CCK) and also in several interneuron subpopulations
expressing somatostatin (SST). Indeed, we observed a co-expression of
Oxtr and Sst mRNAs in hippocampus (Fig. 1B).















Given the role of OT and this hippocampal region in social
memory, we tested the hypothesis that there is a social memory
deficit of Magel2-KO mice.
Deficit of social memory in Magel2-KO males is rescued by
neonatal OT-treatment
In these, as well as in all following neonatal treatment
experiments, WT and Magel2-KO pups were naïve or treated over
a period of 7 days (starting at birth) with a total of four
subcutaneous administrations of physiological saline (“vehicle”) or
oxytocin (2 µg or ~1mg/Kg over the 7 days; “OT-treatment” or
“+OT”), one single administration per day being performed on
alternate days (Postnatal day P0, P2, P4, and P6).
At adulthood, we investigated social behavior using the three-
chamber test in order to assess social exploration (sociability), the
preference for social novelty (social discrimination) and social
memory (short-term social memory) (Fig. 2A). Adult Magel2-KO
males showed levels of sociability and social discrimination similar
to WT males but exhibited a significant deficit in social memory
(Fig. 2B, Supplementary Fig. 1).
The effects of neonatal OT or vehicle treatment were first
evaluated in WT male adults in the three-chamber test. We found
that neither treatment had any measurable effect on sociability,
social discrimination, or social memory: the amount of time spent
sniffing in different compartments was similar to that recorded in
untreated WT males (Fig. 2B, C). Furthermore, no significant effects
of neonatal OT-treatment in WT animals were detected in widely
used assays to test object recognition and social behavior
(Supplementary Fig. 2A, B), motor activity (Supplementary Fig. 2B)
and anxiety-like behaviors (Supplementary Fig. 2B, C).
Then, vehicle and OT-treatment were administered in Magel2-
KO. Magel2-KO vehicle-treated males presented a social memory
deficit similar to untreated Magel2-KO males (Fig. 2B, D). However,
this deficit was rescued by neonatal OT-treatment (Fig. 2D).
Sociability and social discrimination indices were not affected by
vehicle or OT-treatment (Supplementary Fig. 1).
Cohorts of WT females untreated or treated with vehicle or OT
during infancy were also tested at adulthood (excluding animals in
the estrus phase). In the three-chamber test (Supplementary
Fig. 3A), females preferred to interact with a mouse versus an
empty compartment (sociability) (Supplementary Fig. 3B). How-
ever, in the social discrimination test, a less obvious preference to
interact with a novel female compared with a familiar was
observed (P values of 0.03 or 0.06) (Supplementary Fig. 3B, C) as
previously reported [37]. Finally, all females failed in the short-
term social memory test (Supplementary Fig. 3B, C). OT-treatment
in the first week of life improved the level of sociability and of
social discrimination showing a significant increase of sniffing time
Fig. 1 Expression of Magel2 and Oxytocin receptor (Oxtr) transcripts in hippocampus of wild-type male mice at P7 and P28. A
Representative image obtained by RNAscope technology showing the respective localization of Magel2 (blue) and Oxtr (pink) transcripts in
dentate gyrus (DG) and aCA2/CA3d region of hippocampus. B Representative image obtained by RNAscope technique showing the respective
localization of Sst (blue) and Oxtr (pink) transcripts in the aCA2/CA3 region from hippocampal slices of WT male pups at P10. Arrows indicate
co-localization of both transcripts in the same cell. Scale bar: 100 µm.
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Fig. 2 Social behavior in the three-chamber test of adult male WT versus Magel2 KO and adult male WT or Magel2 KO vehicle-treated or
OT-treated as neonates. A Paradigm of the three-chamber test. Sniffing time between mice is measured in each test. B WT males (N= 12)
show normal behavior in all the steps of the test; Magel2 KO males (N= 9) show a significant impairment in short-term social memory. C WT
mice were treated in the first week of life with vehicle or OT and then tested at 4 months. WTmice treated with vehicle (N= 18) or treated with
OT (N= 10) have similar profiles with significant differences in each step of the test. D Magel2 KO mice were treated in the first week of life
with vehicle or OT and then tested at 4 months. Magel2 KO-vehicle (N= 19) mice show a significant difference in the social exploration and
social discrimination, but, in short-term social memory, they do not show a higher sniffing time with the novel mouse. OT-treated Magel2 KO
(N= 19) mice present significant differences in each step of the test. Data represented in histograms report the interaction time (time of
sniffing in seconds) as mean ± SEM. Paired t test. *P < 0.05; **P < 0.01; ***P < 0.001. Statistical analysis is reported in Supplementary Table 1.
A. Bertoni et al.
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towards a conspecific compared with the vehicle or nontreated
females but female mice still failed in the short-term social
memory task (Supplementary Fig. 3C). Using the same battery of
tests as in males, we also showed no effects of neonatal OT-
treatment of WT females in anxiety-like behavior or novel object
recognition but females treated with OT show significantly
reduced distance moved in an open field (Supplementary Fig. 2).
Overall, as this study aimed to investigate OT-dependent social
memory mechanisms in mutant compared with wild-type mice, in
absence of a female positive control group we decided to limit
further study of mechanisms to males only.
Thus, the loss of Magel2 causes a deficit in social memory in
male Magel2-KO adults. This deficit was rescued by a neonatal OT-
treatment. Due to the robust effect observed on social memory,
we focused our subsequent investigations on the hippocampal
region, previously shown to be specifically involved in OT-
mediated effects on social memory [25, 26]. Neurons expressing
the OXTRs in the CA2/CA3d and DG regions of the anterior
hippocampus are involved in social memory [25, 26] therefore we
tested the hypothesis that those regions are involved in the social
memory deficit of Magel2-KO mice.
Social memory test activates aDG and aCA2/CA3d in WT and
Magel2-KO mice
WT and Magel2-KO mice were sacrificed 90min after the end of
social memory test (+SI, for Social Interactions) or without being
tested (−SI) and their brains examined for cFos immunolabeling, a
marker of neuronal activity, in the aDG and aCA2/CA3d regions
(Fig. 3A, B). WT-SI and Magel2-KO-SI mice showed a similar
quantity of cFos positive cells in both regions. In the aCA2/CA3d
region, WT+ SI versus WT− SI (Fig. 3C, D) showed a significant
increase (×1.8) in the number of cFos+ cells; an increase (×2.2)
was also observed in Magel2-KO+ SI mice compared with Magel2-
KO− SI (Fig. 3C, D), notably a tendency (P= 0.052) with an
increase (×1.2) of cFos activated cells was observed in Magel2-KO
+ SI compared with WT+ SI (Fig. 3D). In the aDG, mainly in the
hilus and stratum granulare, a significant increase of ~60% of cFos
+ cells was observed in both WT+ SI and Magel2-KO+ SI
compared with untested (−SI) mice (Fig. 3C, E). Overall, these
data confirm a strong activation of neurons in aDG and aCA2/
CA3d regions following the social memory test in both WT and
Magel2-KO mice, with an increased activation in the aCA2/CA3d
Magel2-KO region.
High levels of OT-binding sites in Magel2-KO hippocampi are
reduced by neonatal OT-treatment
We then looked at the distribution of OT-binding sites, reflecting
the presence of functional OXTRs, in Magel2-KO-vehicle or Magel2-
KO+OT compared with WT-vehicle hippocampi by autoradio-
graphy (Fig. 4). We observed a significant increase of OT-binding
sites in the aCA2/CA3d (100%, Fig. 4A, B) and aDG (80%, Fig. 4C, D)
regions but not in the ventral region (Fig. 4E, F) of Magel2-KO mice
compared to WT. In Magel2-KO+OT we observed a normalization
of the amount of OT-binding sites in the aDG (Fig. 4C, D); this
amount is also decreased in the aCA2/CA3d region but remains
high compared to the WT (Fig. 4A, B). This binding study indicates
subregion-specific modulation of OXTRs in the hippocampus of
Magel2-KO compared with WT. We then wondered if this specific
effect could be linked to changes in neuronal subpopulations in
these subregions.
An increased number of SST+ neurons in the aCA2/CA3d and
aDG regions of Magel2-KO adult mice is normalized by
neonatal OT-treatment
In the anterior adult hippocampus, OXTRs are expressed in
pyramidal cells of aCA2/CA3d region and mainly in SST and/or PV
interneurons of aCA2/CA3d and aDG [25, 29]. In Magel2-KO adult
mice, the number of SST+ cells was significantly higher than in WT
mice in both aCA2/CA3d (60% more) and aDG (80% more) regions
(Fig. 5A–F, M, N). After a neonatal OT-treatment in Magel2-KO, the
number of SST+ cells was slightly but significantly decreased in
both aCA2/CA3d (10% less) and DG regions (17% less) compared
with WT-vehicle mice (Fig. 5G–L, M, N); OT-treatment of Magel2-KO
pups has significantly impacted the number of SST+ neurons at
adulthood. PV+ cells were equally abundant in both genotypes
(Supplementary Fig. 4). We then expected that the change in the
number of SST+ cells had consequences in the alteration of the
excitation/inhibition (E/I) balance, an electrophysiological feature
frequently associated with multiple neurodevelopmental disorders.
Neonatal OT-treatment normalizes the increased GABAergic
activity in Magel2-KO aCA2/CA3d neurons but reduces the
glutamatergic activity in both mutant and WT mice
Hippocampal brain slices of WT, Magel2-KO, WT+OT and Magel2-
KO+OT male mice were analyzed using whole-cell patch clamp to
record the activity of aCA2/CA3d pyramidal neurons (Fig. 6A).
Spontaneous activities analysis (Fig. 6B) revealed a reduced
amplitude of postsynaptic glutamatergic currents (sGlut-PSCs) in
Magel2-KO as compared to WT mice (×1.7 less, Fig. 6C), while the
frequency of sGlut-PSCs was not changed (Fig. 6D). The same
Magel2-KO neurons presented a significant increase in GABAergic
(sGABA-PSCs) frequency (×1.8, Fig. 6E), while the amplitude of
sGABA-PSCs was similar to that of WT (Fig. 6F). Patch clamp
recordings of the glutamatergic and GABAergic miniature currents
(mGlut-PSCs and mGABA-PSCs, respectively) showed a significant
reduction in amplitude of mGlut-PSCs, with no change in their
frequency, in Magel2-KO neurons compared to WT (×1.4 less,
Supplementary Fig. 5B, C), but no differences in frequencies and
amplitudes of mGABA-PSCs (Supplementary Fig. 5D, E). An
abnormal dendritic morphology of the pyramidal neurons could
be associated with the alterations of the neuronal activities.
However, we showed that dendritic morphology of Magel2-KO and
WT CA3-pyramidal neurons were similar (Supplementary Fig. 6).
Altogether, those results show that, in Magel2-KO pyramidal
neurons of aCA3d, there is a significant increase in the GABA/
Glutamate ratio with no change in their neuronal morphology.
We next investigated the effects of OT-treatment on the GABA/
Glutamate balance in WT and Magel2-KO neurons. Quite
unexpectedly, the frequency (×3 less) and amplitude (×1.7 less)
of sGlut-PSCs were significantly reduced in WT+OT mice
compared with WT (Fig. 6C, D). In Magel2-KO mutants, OT-
treatment did not modify the amplitude but reduced the
frequency (×2.9 less) of sGlut-PSCs compared with Magel2-KO
mice (Fig. 6C, D). The GABAergic activity (amplitude and
frequency) was not changed in WT mice after an OT-treatment
(Fig. 6E, F). In Magel2-KO, OT-treatment decreased (×1.9 less)
significantly the frequency of sGABA-PSCs restoring a frequency
similar to WT (Fig. 6E); no effect OT-treatment was observed on
the amplitude of sGABA-PSCs (Fig. 6F). These results show that OT
administration in the first week of life normalized the frequency of
spontaneous GABAergic activity in Magel2-KO neurons. Neonatal
OT-treatment strongly reduced the frequency of glutamatergic
activity in Magel2-KO and the reduction was even stronger on the
amplitude and frequency in WT mice. Notably, WT mice had
normal behaviors (Supplementary Fig. 2).
A delay of the excitatory-to-inhibitory developmental GABA
shift in Magel2-KO hippocampal neurons is corrected by
neonatal OT-administration
Because Oxtr and Magel2 are co-expressed in aCA2/CA3d hippo-
campus in infancy (P7), and because in Oxtr KO mice [36], as in
several models [38] of autism, the depolarizing to hyperpolarizing
developmental GABA shift is delayed, we investigated the GABA-
shift timing in Magel2-KO pups. First, we performed calcium (Ca2+)
imaging experiments by measuring the percentage of neurons
showing GABA-induced Ca2+ responses in developing hippocampal
A. Bertoni et al.
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Fig. 3 cFos activity in aCA2/CA3d and aDG regions of Magel2 KO and WT adult male mice following the social memory task in the three-
chamber test. A Paradigm of the three-chamber test (+SI) followed 90min later by dissection of the brains and immunohistochemistry
experiments. Control mice (−SI) were not tested in the three-chamber test. B, C cFos immunolabeling on coronal brain sections in the aCA2/
CA3d and aDG regions as indicated in (B) of WT-SI, Magel2 KO-SI, WT+ SI and Magel2 KO+ SI mice (C). D, E Quantification of cFos+ cells/
section in WT-SI (n= 40, N= 5), WT+ SI (n= 31, N= 4), Magel2 KO− SI (n= 32, N= 4) and Magel2 KO+ SI (n= 30, N= 4) in the aCA2/CA3d
region (D) and in the aDG region (E). N number of animals, n number of sections. Scale bar: 500 µm (B); 100 µm (C). Data represented in
histograms report the number of cFos+ cells by sections (6–8 sections/animal) as mean ± SEM for the genotype and treatment, with single
gray data point (triangle) showing the average for each section level among all individuals of each group (since sections are repeated
measures) and single black data point (circle) showing the mean value (of all sections) for each animal. Mixed model with repeated
measurements+ Tukey’s post hoc test, ***P < 0.001. Statistical analysis is reported in Supplementary Table 2.
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neuronal cultures of Magel2-KO and WT embryos collected at E18.5
d.p.c. (DIV0 for days in vitro 0) (Fig. 7A, B). At DIV4, we found a
significant two-fold higher proportion of Magel2-KO neurons
increasing Ca2+ upon GABA stimulation compared with WT. This
difference was abolished at DIV8 and DIV11 with a marked decrease
of the percentage of responsive neurons in both genotypes. In
Magel2-KO, KCl-stimulation did not increase Ca2+ responses at DIV2,
DIV4 and DIV8 compared to WT (Supplementary Fig. 7B), suggesting
that the voltage-operated calcium channels were not responsible for
the higher proportion of Magel2-KO GABA evoked neuronal
responses upon stimulation. Altogether, these results showed a
developmental delay in GABA-induced Ca2+ responses in cultures of
Magel2-KO embryonic hippocampal neurons and suggest a devel-
opmental GABA-shift delay in Magel2-KO hippocampal neurons.
Cell-attached recordings of single GABAA channels/receptors
were then performed in acute brain slices in order to measure
the Driving Force of GABAA (DFGABA) and therefore the
hyperpolarizing or depolarizing response of GABA under condi-
tions where intracellular chloride levels are not altered by the
recording pipette. At P1, we observed a tendency to an increase of
DFGABA in Magel2-KO compared with WT; at P7, the DFGABA was
significantly increased (x1.8) in mutant neurons but this difference
was abolished at P15 (Fig. 7C). Since Magel2 and Oxtr are
expressed in interneurons (INs), in which a GABA shift has been
also described [39], we also measured the DFGABA in INs and
observed similar values in CA3 interneurons of mutant and WT
mice (Supplementary Fig. 7C). At P7, the resting membrane
potential (Supplementary Fig. 7D), the capacitance (Supplemen-
tary Fig. 7E) and the conductance (Supplementary Fig. 7F) did not
differ statistically between WT and Magel2-KO neurons. Altogether
these data suggest a transient higher GABA depolarizing activity
at P7 in CA3-pyramidal neurons of Magel2-KO pups and
consequently a delay in GABA shift. Then, at P7, we assessed
the effect of the neonatal OT-administration in Magel2-KO and WT
Fig. 4 Quantification of OT-binding sites by brain autoradiography in the adult hippocampus of Magel2 KO male mice treated with OT or
vehicle versus WT-vehicle male mice. A, C, E Representative sections of autoradiographic labeling of OT-binding sites displayed in grayscale,
showing the regions of interest (ROI) selected for analysis: (A) anterior CA2/CA3 (aCA2/CA3), (C) dentate gyrus (aDG), and (E) ventral CA1/CA2/
CA3 (vCA1/CA2/CA3) regions of hippocampus. B, D, F Quantification of OT-binding sites expressed as nCi/mg of tissue equivalent in (B)
anterior CA2/CA3, (D) dentate gyrus, and (F) ventral CA1/CA2/CA3 regions of hippocampus. Histograms report median (Q2) and quartiles (Q1,
Q3). OT-binding sites in nCi/mg of tissue equivalent. Three mice and six hippocampi have been analyzed for each group. Data represented in
box-plots report the quantity of radiolabeling by hippocampus, with scattered plots that show individual data points. One-way ANOVA+
Bonferroni post hoc test, **P < 0.01; ****P < 0.0001. Scale Bar: 3 mm. Statistical analysis is reported in Supplementary Table 3.
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neonates compared with WT-vehicle pups. Both Magel2-KO+OT
and WT+OT mice showed a significant decrease (x2.4 less and x2
less, respectively) in the DFGABA values compared with WT-vehicle
(Fig. 7D), suggesting a reduction in GABA depolarizing activity
following a neonatal OT-administration.
Post-translational changes in cation-chloride co-transporter
KCC2 in Magel2-KO hippocampus
We then asked if the altered DFGABA values could be due to
alteration in the expression of the neuronal transporters of Cl− in
Magel2-KO mice. The neuronal level of [Cl−]i and Cl-dependent
depolarizing or hyperpolarizing strength of GABA are determined
by complex mechanism involving primarily Cl− extrusion by
potassium/chloride co-transporter type 2 (KCC2) whose expression
increases progressively during neuronal maturation [40]. In
developing WT hippocampal neurons, the emerging activity of
KCC2 contributes to progressive lowering of [Cl−]i that at P7 shifts
GABA action from depolarizing to hyperpolarizing. As conse-
quence, the activation of GABAAR produces neuronal Cl
- influx.
Quantitative western blot analysis of the total KCC2 protein
expression in hippocampi of P7 mice did not reveal statistically
significant difference of the amount of KCC2 between WT and
Magel2-KO animals (Fig. 7E, F). However, the ion-transport activity
of KCC2 and its stability at the cellular plasma membrane depend
on post-translational modifications of multiple phosphorylation
sites [41]. We therefore used phospho-site-specific antibodies,
previously shown to quantitatively monitor changes in KCC2
phosphorylation [42, 43]. Currently, a limited number of such
phospho-specific antibody is available. They are directed against
the well-known KCC2’s phospho-sites Ser940 [44] and Thr1007
[42, 43]. Western blot analysis revealed that the Magel2-KO
hippocampi (as compared to WT) were characterized by
Fig. 5 Quantification of somatostatin (SST) immunopositive cells in the anterior hippocampus region of adult Magel2 KO, WT, Magel2 KO
treated with OT and WT-vehicle male mice. A–L Immunolabeling on coronal hippocampal sections at adulthood in WT (A, C, E) and Magel2
KO (B, D, F), and in WT-vehicle (G, I, K) and Magel2 KO+OT (H, J, L) with a magnification in the aCA2/CA3d region (C, D, I, J) and in the DG
region (E, F, K, L) in which the SST+ cells are counted. M, N Number of SST+ cells by section in both aCA2/CA3d (M) and aDG (N) and
comparing WT (N= 4, n= 56), Magel2 KO (N= 4, n= 55), WT-vehicle (N= 3, n= 36), and Magel2 KO+OT (N= 5, n= 64) mice. N, number of
animals; n, number of sections/hippocampus. Data represented in histograms report the number of SST+ cells by section as mean ± SEM, with
single gray data point (triangle) showing the average for each section level among all individuals of each group (since sections are repeated
measures) and single black data point (circle) showing the mean value (of all sections) for each animal. Mixed model with repeated
measurements+ Tukey’s post hoc test. **P < 0.01; ***P < 0.001. Scale bar (A–H): 500 µm; (C–L): 100 µm. Statistical analysis is reported in
Supplementary Table 4.
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significantly decreased amount of the phosphorylated form of
Ser940 (P-Ser940). The amount of phosphorylated Thr1007 (P-Thr1007)
was not statistically different, although a small but not significant
increase was observed in Magel2-KO mice (Fig. 7E, F). At P7, the
decreased P-Ser940/P-Thr1007 ratio in Magel2-KO mice may thus
result in predominance of KCC2 internalization over surface
expression. As a consequence of the decreased amount of surface
expressed molecules, the Cl- extrusion ability of KCC2 is decreased,
causing an increase of [Cl−]i and could induce a depolarizing shift
of GABA described above (Fig. 7G).
DISCUSSION
Here we investigated, in hippocampus, the mechanisms by which
peripheral administration of OT in neonates acts to restore normal
social memory in Magel2-KO mice. Peripheral OT-administration in
neonates permanently rescued almost all the hippocampal altera-
tions (quantity of OT-binding sites, number of SST-positive
interneurons and an increase in the GABAergic activity of pyramidal
neurons) that we have characterized and that are associated with
the increase of GABAergic activity observed in Magel2-KO adult
mice; but a decrease of glutamatergic activity is still present. Those
alterations are related with the OT-signaling pathway and relevant
to explain the loss of social memory. However, a significant impact
of OT-treatment, reducing the glutamatergic activity, was also
observed in wild-type mice but all performed behavioral tests were
normal. A significant effect of OT-administration on the delayed
excitatory-to-inhibitory developmental GABA shift (at P7), delays
that are observed in various neurodevelopmental disorders, under-
lies the therapeutic use of neonatal oxytocin in these disorders.
The effect of peripheral OT-administration in Magel2-KO
neonates
Adding to our previous work on OT-treatment in Magel2-KO
neonates, we have shown long-term and beneficial effects of a
peripheral administration of OT in Magel2-KO neonates that
rescues nearly all social and cognition deficits described in adult
Magel2-KO mice [16], including social memory described here.
However, previously, we did not investigate neither the neuro-
biological causes of these deficits nor the effects of OT on those
alterations. We focused this study on social memory because the
mechanisms by which OT controls social memory via the OXTR-
expressing neurons in hippocampus are known. We clearly
demonstrated that: (1) the neurobiological alterations found in
Magel2-KO mice involve the hippocampal brain OT-circuitry and
(2) peripheral administration of OT in neonates impacts this
circuitry. Thus, those results give a clear and positive response to
the debated question on the action of peripheral administration of
OT on the brain. Does peripheral OT produce direct central effects
by crossing the Blood–Brain–Barrier (BBB) or indirect effects via a
peripheral route? It might be both. Recent studies suggest that
peripheral OT goes through the BBB via an active mechanism
using RAGE transporters [45, 46] and/or a passive mechanism, in
neonates, when this barrier is more permeable, and/or perhaps by
modulating peripheral sensory afferents [47–49] to enhance
endogenous production and/or release of OT.
Fig. 6 Spontaneous Glutamatergic and GABAergic synaptic activity of CA3-pyramidal neurons in the anterior hippocampus region of
Magel2 KO mice versus WT juvenile mice with or without OT-treatment as neonates. A Paradigm of the test. WT or Magel2 KO mice were
either not injected or were injected with OT in the first week of life. At P20–25, neurons were recorded in brain slices. B Examples of whole-cell
recordings performed at a holding potential of −45mV for each genotype or treatment. The glutamatergic synaptic currents are inwards and
the GABAergic synaptic currents are outwards. C, D Values in the different genotypes and treatment of the Glut-sPSCs amplitude (C) and
frequency (D). E, F Values in the different genotypes and treatment of the GABA-sPSCs frequency (E) and amplitude (F). Magel2 KO (N= 7, n=
16), WT (N= 7, n= 15), Magel2 KO+OT, (N= 5, n= 21) and WT+OT (N= 4, n= 15) have been analyzed, with N number of mice and n number
of recorded cells. Data represented in box-plots report the different values of recorded cells with mean ± SEM, with scattered plots showing
individual data points. One-way ANOVA+ Tukey post hoc test. *P < 0.05; **P < 0.01. Statistical analysis is reported in Supplementary Table 5.
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The observed long-lasting OT effects could result from a strong
impact of OT administration in key developmental hippocampal
processes such as the developmental GABA shift (as discussed
below) and can also be achieved by epigenetic modifications that
impact gene expression such as Oxtr expression, as observed in
prairie voles following maternal OT administration [50]. Transcrip-
tomic and proteomic studies at different developmental ages
would help to understand the life-long effect of an early OT-
treatment in mutant and WT mice.
The lack of Magel2 alters the OT-system: causes and
consequences
Magel2 is expressed in hypothalamic OT neurons and, in Magel2-
KO neonates, we observed a deficit in the quantity of the mature
form of OT although we detected an accumulation of the
intermediate non-mature forms of OT suggesting a problem of
hormonal processing [18]. Here we showed a co-expression of
Magel2 and Oxtr transcripts in the hippocampal neurons. Thus,
given the role of MAGEL2 in ubiquitination, actin regulation and
A. Bertoni et al.
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endosomal sorting processes [51], the absence of Magel2
expression could induce post-translational modifications of
various processes in OT and OXTR-expressing neurons, suggesting
that dysregulation of the OT-system in Magel2-KO mice goes
beyond OT expression.
Here we showed that the excitatory-to-inhibitory GABAergic
developmental sequence is transiently delayed in Magel2-KO
pyramidal neurons during the first week of life, with GABAA-
mediated responses more depolarizing in Magel2-KO than WT
mice at P7. We further showed that this electrophysiological
deficit corresponds well with decreased functional KCC2 at the cell
membrane, indicated by a deficit of KCC2 phosphorylation (on
Ser940). Notably, Ser940-phosphorylation is controlled by OXTR
activation via a PKC-dependent pathway and allows translocation
of KCC2 to the cell membrane [36], enhancing KCC2 mediated Cl−
transport [44, 52]. This mechanism is relevant to control the
GABAergic developmental sequence in vitro and possibly in vivo
[53].
The functional consequences of this delayed developmental
GABA shift in Magel2-KO pyramidal neurons are not clearly
established. However, there are compelling reasons to suspect
that transient disruption of GABAergic maturation in the immedi-
ate postnatal period might be sufficient to permanently alter
neural circuit dynamics. Indeed, P7 is a critical milestone in the
development of GABAergic neurons in the mouse neocortex and
hippocampus, characterized by major changes in network
dynamics (e.g., the end of in vitro giant-depolarizing-potentials
[54] and in vivo early sharp waves [55]), intrinsic membrane
properties (e.g., input resistance) and synaptic connectivity [56].
Altogether those data suggest that the absence of Magel2 delays
neuronal maturation during this critically vulnerable period of brain
development, resulting in a distinct adult phenotype. Whether the
delay of the GABA shift alone is sufficient to derail neurotypical
developmental trajectory remains a key question for future study:
notably, similar or longer GABA-shift delays have been observed in
several models of autism [57–59] and in Oxtr KO mouse models
[36]. Recently, Kang et al. [60] showed, in a Disc1 KO mouse model,
that elevated depolarizing GABA signaling is a precursor for the
later E/I imbalance (in favor of inhibition) and social impairment.
Similarly, we previously showed that, in a KCC2 mutant mouse, the
GABA-shift delay is responsible for the E/I alteration [53].
Importantly, OT-treatment increases the GABA hyperpolarizing
activity at P7, during the period of the excitatory-to-inhibitory
GABA shift and might accelerate this shift. This effect of OT-
treatment might modify the maturation of the hippocampal
circuitry.
The E/I ratio and social behavior
Reductions in synaptic signal-to-noise ratio in cortical and
hippocampal pyramidal neurons, driven by a change in the ratio
of dendritic excitatory and inhibitory synapses, are widely
thought to contribute to reduced efficiency of signal processing
in ASD, a mechanism known as the E/I ratio hypothesis [61]. We
confirm E/I imbalance characterized by increased GABAergic
activity and lower glutamatergic activity in CA3 neurons in
Magel2-KO mice, consistent with observations made in some
ASD models [62–64]. Furthermore, we report that perinatal OT
administration restored normal GABAergic activity in Magel2-KO
mice without improving glutamatergic transmission. Unexpect-
edly, perinatal OTtreatment has a significant impact on the WT
neurons inducing a strong reduction of glutamatergic activity
without affecting GABAergic activity. This is a significant
observation, because it shows that, although the ASD-like
behavior of Magel2-KO animals is correlated with a change in
E/I ratio, E/I imbalance in OT-treated WT animals was not
sufficient to drive detectable changes in social behavior or in the
novel object recognition test. We therefore propose that E/I
imbalance characterized by isolated decreased spontaneous
glutamatergic transmission is unlikely to underlie the ASD traits
investigated here, and suggest that an upper threshold of
GABAergic or glutamatergic activity, but not the E/I ratio per se,
may be important for normal development.
Role of oxytocin receptors and somatostatin neurons
In adult Magel2-KO mice we observed increased OT-binding in the
DG and CA2/CA3 regions of the anterior hippocampus compared
to WT mice. OT administration in Magel2-KO neonates normalized
hippocampal OT-binding sites in adulthood, suggesting that the
increased expression of OXTR observed in Magel2-KO hippocam-
pus may be a consequence of the reduced OT production
reported in these animals [18]. This observation supports the idea
that life-long OXTR expression is to some extent determined by
Fig. 7 The excitatory-to-inhibitory developmental GABA shift in Magel2 KO versus WT hippocampi and the effect on an OT-
treatment. Abundance and phosphorylation state of KCC2 in WT and Magel2 KO pups in relation with this GABA shift. A, B GABA-induced
Ca2+ responses in Magel2 KO developing hippocampal neuronal cultures versus WT. A Percentage of WT and Magel2 KO E18 hippocampal
neurons showing GABA-induced Ca2+ responses at selected in vitro days (DIV). B Representative traces of [Ca2+]i variations (delta F340/380) in
DIV4 WT and Magel2 KO neurons upon 100 μM GABA administration. Data are presented in histograms with mean ± SEM; unpaired t test with
Welch’s correction: ****P < 0.0001. C, D Measures of the driving force for GABA (DFGABA), using cell-attached recordings of single GABAA
channels, of aCA3d pyramidal neurons. C Average values of the DFGABA at P1, P7, and P15 in Magel2 KO (P1 N= 3, n= 20; P7: N= 7, n= 56;
P15: N= 4, n= 29) versus WT (P1 N= 3, n= 19; P7: N= 6, n= 42; P15: N= 3, n= 23) mice. Data are presented in histograms with mean ± SEM;
unpaired t test with Welch’s correction: *P < 0.05. D Graph reporting the relative changes of the DFGABA at P7 in untreated Magel2-KO mice (N
= 7, n= 56) compared with WT mice (N= 6, n= 42) and in OT-treated WT (N= 3, n= 37) and Magel2-KO (N= 4, n= 56) mice compared with
WT-vehicle (N= 3, n= 37) mice. N number of mice and n number of recorded cells. One-way ANOVA+Dunnett’s post hoc test: **P < 0.01. E, F
Abundance and phosphorylation state of KCC2 in WT and Magel2 KO pups. E Immunoblot analysis of WT (N= 5) and Magel2 KO (N= 6)
hippocampi of P7 mice with pan-KCC2 antibody or phosphorylation site-specific antibodies recognizing P-Ser940 or P-Thr1007 of KCC2. A
neuron-specific ß3 tubulin antibody was used to normalize the quantity of proteins. Numbers on the left indicate molecular weight. F Box-
plots report band intensities from (E) as Q2 (Q1, Q3), with scattered plot showing individual data points. Mann–Whitney test, *P < 0.05. G A
model of KCC2-dependent control of neuronal Cl− in Magel2 KO pups. At P7, the surface expression of KCC2, that determines its ion-transport
activity, depends on the ratio of reciprocal phosphorylation of its Ser940 and Thr1007 residues. Ser940 phosphorylation increases KCC2’s cell
surface stability, whereas Thr1007 phosphorylation exerts opposite to Ser940 effect and favors internalization (brown arrows). Compared to WT,
the CA3 neurons in hippocampi from Magel2 KO mice are characterized by depolarizing action of GABA (e.g., activation of GABA generates Cl-
efflux) that reflects higher [Cl-]i. In Magel2 KO hippocampi the amount of KCC2’s Ser
940 phosphorylation is significantly lower as compared to
WT hippocampi whereas the amount of phosphorylated Thr1007 remains unchanged. Respectively, the decreased P-Ser940/P-Thr1007 ratio is
predicted to result in predominance of KCC2 internalization over surface expression. We hypothesize, as a consequence of the decreased
amount of surface expressed KCC2, the Cl− extrusion is decreased, leading to increased [Cl−]i and a depolarizing shift of GABA. The model
includes also important components that are known to control the level of Ser940 and Thr1007 phosphorylation. Ser940 is directly
phosphorylated by kinase C (pkC) and dephosphorylated under pathology conditions by protein phosphatase type 1 (PP1). Thr1007 is directly
phosphorylated by SPAK. Statistical analysis is reported in Supplementary Table 6.
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early life OT-binding, described as a “hormonal imprinting” effect
[50, 65].
Since DG and CA2/CA3 hippocampal OXTRs are expressed in PV
and SST interneurons, we quantified those populations and found
a significant increase in the number of aDG and aCA2/CA3d SST+
neurons in mutant mice, while the number of PV+ interneurons
was not modified. OT-treatment of pups normalized the number
of SST-expressing neurons in Magel2-KO adults, revealing a causal
link between the administration of OT in infancy and the quantity
of SST+ neurons in adulthood. This result may reflect actual
changes in the number of SST+ neurons, or alternatively changes
in SST expression and hence more reliable detection of SST-
synthesizing neurons. Interestingly, OT modulates the activity of
the SST+ neurons, increasing the excitability of SST interneurons
[66] but no studies report an effect of OT on SST production.
SST interneurons have recently been shown to play a role in the
modulation of social behavior [67, 68] and a link between altered
social memory and an increase in SST cell number has been
recently suggested in LPS-treated female neonates [69]. It is
tempting to speculate that OXTR-transmission regulates the
activity of SST hippocampal interneurons and the production/
release of mature SST and impacts social memory. Further work is
needed to fully characterize the role of OXTRs on SST interneurons
in relation with social memory.
The lack of short-term social memory in wild-type females
In wild-type females, the results on social exploration and
discrimination are in agreement with previous studies [37, 70].
The lack of preference by wild-type females for a novel female
mouse in the short-term social memory task is puzzling. This result
was obtained in four different cohorts (two are not shown and the
OT-treated cohort is excluded), indicating that it is highly
reproducible. We cannot compare our results with other studies
due to the lack of similar studies reported in the literature using
this three-chamber paradigm with the short-term social memory
task (Raam et al. [25] studied only males). However, our present
results clearly question the validity of this test for assessing social
memory in females. In addition, it suggests a new important
question that will need to be addressed: do adult females prefer to
interact with familiars and are not interested in exploring novel
same-sex congeners? Indeed, in the discrimination test, females
showed lower levels of novelty exploration compared with males,
as observed in this study and by Karlsson et al. [37]. Interestingly,
Moy et al. [71] did not find this sex difference when they tested
juvenile females and used juvenile males as stimuli, suggesting
that it may be an age-related behavior. We should consider that
social memory is stimulus-dependent and sexual dimorphism
exists in social behavior to interact with a novel conspecific of the
same sex. A role for oxytocin in short-term social memory has
been clearly revealed in males but females have not been properly
studied. Interestingly, it has also recently been shown that the
action of OT on the same neurons regulates distinct behaviors by
sex [72, 73]. Further studies are needed to clarify why females
show low interactions towards novel conspecifics and what are
the differences in social memory between male and female mice
during the different phases of life.
CONCLUSIONS
Oxytocin deficiency, present in the Magel2-KO mouse model and
in PWS, has also been frequently described in rodent models of
ASD [2]. Recently, evidence for a unifying role of oxytocin in
pathogenic mechanisms responsible for social impairments across
a broad range of autism etiologies have been provided [74, 75].
Thus, our results demonstrate that peripheral OT-administration in
a critical period of time, after birth, represents a viable therapeutic
strategy for patients with SYS or PWS and possibly other
neurodevelopmental disorders.
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